Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 136, Issue 1, 2008, Pages 110-115

  Yoon, Bo Sung ^a   Kim, Young Tae ^a   Kim, Sunghoon ^a   Lee, Chong Seung ^a   Kim, Jae Wook ^a   Kim, Jae Hoon ^a   Kim, Sang Wun ^a   Cho, Nam Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cyclin A; DNA ploidy; Ovarian cancer; Prognostic factors; S phase fraction

Indexed keywords

CARBOPLATIN; CELL NUCLEUS DNA; CYCLIN A; PACLITAXEL;

ADULT; ANEUPLOIDY; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CELL CYCLE S PHASE; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DNA DETERMINATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME;

EID: 37549035944     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.10.008     Document Type: Article

References (34)

1. Holschneider C.H., and Berek J.S. Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19 (2000) 3-10
2. Lavin P.T., Knapp R.C., Malkiasian G., Whitney C.W., Berek J.C., and Bast Jr. R.C. CA-125 for the monitoring of ovarian carcinoma during primary therapy. Obstet Gynecol 69 (1987) 223-227
3. Rustin G.J., Nelstrop A.E., Tuxen M.K., and Lambert H.E. Defining progression of ovarian carcinoma during follow-up according to CA-125: a North Thames Ovary Group Study. Ann Oncol 7 (1996) 361-364
4. Barlogie B., Drewinko B., and Schumann J. Cellular DNA content as a marker of neoplasia in man. Am J Med 69 (1980) 195-203
5. Merkel D.E., Dressler L.G., and McGuire W.L. Flow cytometry, cellular DNA content, and prognosis in human malignancy. J Clin Oncol 5 (1987) 1690-1703
6. Garcia R.L., and Gown A.M. Analysis of proliferative grade using anti PCNA/cyclin monoclonal antibodies in formalin fixed, paraffin embedded tissues, comparison with flow cytometric analysis. Am J Pathol 134 (1989) 733-739
7. Dierendonck J.H., Wijsman J.H., Keijzer R., Velde C.J.H., and Cornrlsse C.J. Cell cycle related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Am J Pathol 138 (1991) 1165-1172
8. Dervan P.A., Magee H.M., and Carney D.N. Proliferating cell nuclear antigen counits in formalin-fixed paraffin-embeded tissues correlate with Ki-67 in fresh tissue. Am J Clin Pathol 97 (1992) 21-28
9. Huettner P.C., Weinberg D.S., and Lage J.M. Assessment of proliferative activity in ovarian neoplasms by flow and static cytometry. Am J Pathol 141 (1992) 699-706
10. Yu C.C.W., Woods A.L., and Levison D.A. The assessment of cellular proliferation by immunochemistry; a review of currently available methods and there applications. Histochem J 24 (1992) 121-131
11. Volm M., Kleine W., and Pfleiderer A. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study. Gynecol Oncol 35 (1989) 84-89
12. Friedlander M.L., Heldey D.W., and Swanson C. Prediction of long-term survivals by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. J Clin Oncol 6 (1988) 282-290
13. Rice L.W., Mark S.D., Berkowitz R.S., Goff B.A., and Lage J.M. Clinicopathologic variables, operative characteristics, and DNA ploidy in predicting outcome in ovarian epitheilial carcinoma. Obstet Gynecol 86 (1995) 379-385
14. Meyer J.S., Gorsell D.J., and Yim S. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Gynecol Oncol 81 (2001) 466-476
15. Lock L.F., and Wickramasinghe D. Cycling with CDKs. Trends Cell Biol 4 (1994) 404-405
16. Pagano M., Pepperkok R., Verde F., Ansorge W., and Draeta G. Cyclin A is required at two points in the human cell cycle. EMBO J 11 (1992) 961-971
17. Barboule N., Baldin V., Jozan S., Vidal S., and Valette A. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA. Int J Cancer 76 (1998) 891-896
18. Chao Y., Shih Y.L., Chiu J.H., et al. Over-expressopn of cyclin A but not Skp2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res 58 (1998) 985-990
19. Serov F., Scully R.E., and Solbin L.E. Histologic typing of ovarian tumors. International classification of tumors (1973), World Health Organization, Geneva
20. In: Rose N.R. (Ed). Flow cytometric analysis of DNA content in solid tumors. Manual of clinical laboratory immunology (1997), ASM press, Washington
21. Annual Report of the Central Cancer Registry in Korea. Central Cancer Registry Center in Korea. Seoul: Ministry of Health and Welfare, 2003.
22. Omura G.A., Brady M.F., Homesley H.D., et al. Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9 (1991) 1138-1150
23. Baak J.P., Chan K.K., Stolk J.G., and Kenemans P. Prognostic factors in borderline and invasive ovarian tumors of the common epithelial type. Pathol Res Pract 182 (1987) 755-774
24. Kallioniemi O.P., Punnonen R., Mattila J., Lehtinen M., and Koivula T. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer. Cancer 61 (1988) 334-339
25. Barlogie B., Raber M.N., and Schumann J. Flow cytometry in clinical cancer research. Cancer Res 43 (1983) 3982-3989
26. Friedlander M.L., Hedley D.W., Taylor I.W., Russel P., Coates A.S., and Tatersall M.H.N. Influence of cellular DNA content on survival in advanced ovarian cancer. Cancer Res 44 (1984) 397-400
27. Rutgers D.H., Wils I.S., Schaap A.H.P., and van Lindert A.C.M. DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas. Pathol Res Pract 182 (1987) 207-213
28. Hansson J., Tribukalt B., Lewensohn R., and Ringborg U. Flow cytofluorometric analyses of metastases of human malignant melanomas. Anal Quant Cytol 4 (1982) 99-104
29. Meyer J.S., and Coplin M.D. Thymidine labeling index, flow cytometric S-phase measurement, and DNA index in human tumors: comparisons and correlations. Am J Clin Pathol 89 (1988) 586-595
30. Merkel D.E., and McGuire W.L. Ploidy, proliferative activity and prognosis: DNA flow cytometry of solid tumors. Cancer 65 (1990) 1194-1205
31. Hunter T., and Pines J. Cyclins and cancer. Cell 66 (1991) 1071-1074
32. Marx J. How cells cycle toward cancer. Science 263 (1994) 319-321
33. Schutte B., Reyners M.M., and Bosman F.T. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin embedded tissue. Cytometry 6 (1985) 26-30
34. Stephenson R.A., Gay H., Fair W.R., and Melamed M.R. Effect of section thickness on quality of flow cytometric DNA content determinations in paraffin-embeded tissue. Cytometry 7 (1986) 41-44